Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
SHU YONGQIAN, MD
CONTACT
Lead
Nanjing Sanhome Pharmaceutical, Co., Ltd.
The study is designed to evaluate safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of once-daily and orally (PO) administered SH-1028 tablets. The overall study design is shown in the flow chart below, which consists of 2 phases: dose escalation and dose expansion cohort.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
